Non-Face-to-Face Sale and Distribution of Tobacco Products and Advertising, Promotion, and Marketing of Tobacco Products; Extension of Comment Period, 76096-76097 [2011-31225]
Download as PDF
<![CDATA[
76096
Federal Register / Vol. 76, No. 234 / Tuesday, December 6, 2011 / Proposed Rules
that (i) Has been determined to be subject to
the EAR in a commodity jurisdiction
determination issued by the U.S. Department
of State and (ii) is not otherwise identified
elsewhere on the CCL.
10. In Supplement No. 1 to part 774,
Category 0, add Export Control
Classification Number 0E606 between
Export Control Classification Numbers
0E018 and 0E918 to read as follows:
0E606 Technology ‘‘required’’ for the
‘‘development,’’ ‘‘production,’’
operation, installation, maintenance,
repair, or overhaul, of ground vehicles
and related commodities in 0A606,
0B606, 0C606, or 0D606.
License Requirements
Reason for Control: NS, RS, AT
Control(s)
NS applies to entire
entry, except
0E606.y.
RS applies to entire
entry, except
0E606.y.
AT applies to entire
entry.
tkelley on DSK3SPTVN1PROD with PROPOSALS-1
[FR Doc. 2011–30976 Filed 12–5–11; 8:45 am]
BILLING CODE 3510–33–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1140
[Docket No. FDA–2011–N–0467]
RIN 0910–AG43
Non-Face-to-Face Sale and
Distribution of Tobacco Products and
Advertising, Promotion, and Marketing
of Tobacco Products; Extension of
Comment Period
Country chart
NS Column 1
RS Column 1
AGENCY:
Food and Drug Administration,
HHS.
Advance notice of proposed
rulemaking; extension of comment
period.
ACTION:
AT Column 1
License Exceptions
CIV: N/A
TSR: N/A
STA: Paragraph (c)(2) of License Exception
STA (§ 740.20(c)(2)) of the EAR may not be
used for any technology in 0D606.
List of Items Controlled
Unit: N/A
Related Controls: Technical data directly
related to articles enumerated in USML
Category VII are subject to the controls of
USML paragraph VII(h). See ECCN 0A919
for foreign made ‘‘military commodities’’
that incorporate more than 10% U.S.-origin
‘‘600 series’’ items.
Related Definitions: N/A
Items:
a. ‘‘Technology’’ ‘‘required’’ for the
‘‘development,’’ ‘‘production,’’ operation,
installation, maintenance, repair, or
overhaul, of commodities enumerated in
ECCN 0A606 (except for ECCNs 0A606.b or
0A606.y).
b. through w. [RESERVED]
y. Specific ‘‘technology’’ ‘‘required’’ for the
‘‘production,’’ ‘‘development,’’ operation,
installation, maintenance, repair, or
overhaul, of commodities enumerated in
ECCN 0A606.y., 0B606.y, or 0C606.y, as
follows:
y.1. Specific ‘‘technology’’ ‘‘required’’ for
the ‘‘production,’’ ‘‘development,’’ operation,
installation, maintenance, repair or overhaul
of commodities enumerated in ECCN
9A610.y, 9B610.y, 9C610.y, or 9D610.y.
y.2. through y.98 [RESERVED]
y.99. ‘‘Technology’’ that would otherwise
be controlled elsewhere by ECCN 0E606 but
that (i) Has been determined to be subject to
the EAR in a commodity jurisdiction
determination issued by the U.S. Department
of State and (ii) is not otherwise identified
elsewhere on the CCL.
VerDate Mar<15>2010
Dated: November 28, 2011.
Kevin J. Wolf,
Assistant Secretary for Export
Administration.
15:26 Dec 05, 2011
Jkt 226001
The Food and Drug
Administration (FDA) is extending the
comment period until January 19, 2012,
for an advance notice of proposed
rulemaking (ANPRM) that was
published in the Federal Register of
September 9, 2011 (76 FR 55835). In
that document, FDA requested
comments, data, research, or other
information related to non-face-to-face
sale and distribution of tobacco
products; the advertising, promotion,
and marketing of such products; and the
advertising of tobacco products via the
Internet, email, direct mail, telephone,
smart phones, and other communication
technologies that can be directed to
specific recipients. The Agency is
extending the comment period in
response to a request to give interested
parties additional time to comment.
DATES: Submit either electronic or
written comments by January 19, 2012.
ADDRESSES: You may submit comments,
identified by Docket No. FDA–2011–N–
0467 and/or RIN number 0910–AG43,
by any of the following methods:
SUMMARY:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Written Submissions
Submit written submissions in the
following ways:
• FAX: (301) 827–6870.
PO 00000
Frm 00031
Fmt 4702
Sfmt 4702
• Mail/Hand delivery/Courier (for
paper, disk, or CD–ROM submissions):
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville,
MD 20852.
Instructions: All submissions received
must include the Agency name and
Docket No. FDA–2011–N–0467 and
Regulatory Information Number (RIN
0910–AG43) for this rulemaking. All
comments received may be posted
without change to https://
www.regulations.gov, including any
personal information provided. For
additional information on submitting
comments, see the ‘‘Comments’’ heading
of the SUPPLEMENTARY INFORMATION
section of this document.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Division of Dockets
Management, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Beth
Buckler, Center for Tobacco Products,
Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850–
3229, (877) 287–1373,
beth.buckler@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of September
9, 2011 (76 FR 55835), FDA issued an
ANPRM to obtain information related to
the regulation of non-face-to-face sale
and distribution of tobacco products
and the advertising, promotion, and
marketing of tobacco products. FDA
took this action as part of its
implementation of the Family Smoking
Prevention and Tobacco Control Act
(Pub. L. 111–31, 123 Stat. 1776). FDA
requested comments, data, research, or
other information related to non-face-toface sale and distribution of tobacco
products; the advertising, promotion,
and marketing of such products; and the
advertising of tobacco products via the
Internet, email, direct mail, telephone,
smart phones, and other communication
technologies that can be directed to
specific recipients. FDA intends to use
the information submitted in response
to the ANPRM to inform its regulation
of the sale and distribution of tobacco
products through a non-face-to-face
exchange and the advertising,
promotion, and marketing of tobacco
products. FDA provided a 90-day
comment period (i.e., until December 8,
2011) for the ANPRM.
E:\FR\FM\06DEP1.SGM
06DEP1
Federal Register / Vol. 76, No. 234 / Tuesday, December 6, 2011 / Proposed Rules
FDA has received a request to extend
the comment period. The request stated
that additional time is needed to
coordinate factual information and
policy positions with a large number of
States on several of the questions in the
ANPRM. The request noted that their
comments will be more thorough and of
more assistance to FDA if more time is
available to develop them.
FDA has considered the request and
is extending the comment period an
additional 6 weeks, until January 19,
2012. We believe that the additional
time will provide interested parties
sufficient time to submit comments on
the ANPRM.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding this ANPRM. It is
only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: December 1, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–31225 Filed 12–5–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF STATE
22 CFR Part 121
RIN 1400–AC98
[Public Notice 7703]
Amendment to the International Traffic
in Arms Regulations: Establishment of
U.S. Munitions List Category XIX for
Gas Turbine Engines
Department of State.
Proposed rule.
AGENCY:
ACTION:
As part of the President’s
Export Control Reform effort, the
Department of State proposes to amend
the International Traffic in Arms
Regulations (ITAR) to establish Category
XIX of the U.S. Munitions List (USML)
to describe gas turbine engines and
associated equipment warranting
control on the USML.
DATES: The Department of State will
accept comments on this proposed rule
until January 20, 2012.
ADDRESSES: Interested parties may
submit comments within 45 days of the
tkelley on DSK3SPTVN1PROD with PROPOSALS-1
SUMMARY:
VerDate Mar<15>2010
15:26 Dec 05, 2011
Jkt 226001
date of publication by one of the
following methods:
• Email:
DDTCResponseTeam@state.gov with the
subject line, ‘‘ITAR Amendments—
Category XIX, Gas Turbine Engines.’’
• Internet: At www.regulations.gov,
search for this notice by using this rule’s
RIN (1400–AC98).
Comments received after that date will
be considered if feasible, but
consideration cannot be assured. We
will make all comments (including any
personally identifying information or
information for which a claim of
confidentiality is asserted in those
comments or their transmittal emails)
available for public inspection and
copying after the close of the comment
period via the Directorate of Defense
Trade Controls Web site at
www.pmddtc.state.gov. Parties who
wish to comment anonymously may do
so by submitting their comments via
www.regulations.gov, leaving the fields
that would identify the commenter
blank and including no identifying
information in the comment itself.
Comments submitted via
www.regulations.gov are immediately
available for public inspection.
FOR FURTHER INFORMATION CONTACT:
Director Charles B. Shotwell, Office of
Defense Trade Controls Policy,
Department of State, Telephone (202)
663–2792 or Fax (202) 261–8199; Email
DDTCResponseTeam@state.gov. Attn:
Regulatory Change, USML Category
XIX.
SUPPLEMENTARY INFORMATION: The
Directorate of Defense Trade Controls
(DDTC), U.S. Department of State,
administers the International Traffic in
Arms Regulations (ITAR) (22 CFR parts
120–130). The items subject to the
jurisdiction of the ITAR, i.e., ‘‘defense
articles,’’ are identified on the ITAR’s
U.S. Munitions List (USML) (22 CFR
121.1). With few exceptions, items not
subject to the export control jurisdiction
of the ITAR are subject to the
jurisdiction of the Export
Administration Regulations (‘‘EAR,’’ 15
CFR parts 730–774, which includes the
Commerce Control List in part 774),
administered by the Bureau of Industry
and Security (BIS), U.S. Department of
Commerce. Both the ITAR and the EAR
impose license requirements on exports
and reexports. Items not subject to the
ITAR or to the exclusive licensing
jurisdiction of any other set of
regulations are subject to the EAR.
Export Control Reform Update
The Departments of State and
Commerce described in their respective
Advance Notices of Proposed
PO 00000
Frm 00032
Fmt 4702
Sfmt 4702
76097
Rulemaking (ANPRM) in December
2010 the Administration’s plan to make
the USML and the CCL positive, tiered,
and aligned so that eventually they can
be combined into a single control list
(see ‘‘Commerce Control List: Revising
Descriptions of Items and Foreign
Availability,’’ 75 FR 76664 (December 9,
2010) and ‘‘Revision to the United
States Munitions List,’’ 75 FR 76935
(December 10, 2010)). The notices also
called for the establishment of a ‘‘bright
line’’ between the USML and the CCL to
reduce government and industry
uncertainty regarding export
jurisdiction by clarifying whether
particular items are subject to the
jurisdiction of the ITAR or the EAR.
While these remain the
Administration’s ultimate Export
Control Reform objectives, their
concurrent implementation would be
problematic in the near term. In order to
more quickly reach the national security
objectives of greater interoperability
with our allies, enhancing our defense
industrial base, and permitting the U.S.
Government to focus its resources on
controlling and monitoring the export
and reexport of more significant items to
destinations, end uses, and end users of
greater concern than our NATO and
other multi-regime partners, the
Administration has decided, as an
interim step, to propose and implement
revisions to both the USML and the CCL
that are more positive, but not yet
tiered.
Specifically, based in part on a review
of the comments received in response to
the December 2010 notices, the
Administration has determined that
fundamentally altering the structure of
the USML by tiering and aligning them
on a category-by-category basis would
significantly disrupt the export control
compliance systems and procedures of
exporters and reexporters. For example,
until the entire USML was revised and
became final, some USML categories
would follow the legacy numbering and
control structures while the newly
revised categories would follow a
completely different numbering
structure. In order to allow for the
national security benefits to flow from
re-aligning the jurisdictional status of
defense articles that no longer warrant
control on the USML on a category-bycategory basis while minimizing the
impact on exporters’ internal control
and jurisdictional and classification
marking systems, the Administration
plans to proceed with building positive
lists now and afterward return to
structural changes.
E:\FR\FM\06DEP1.SGM
06DEP1
]]>Agencies
[Federal Register Volume 76, Number 234 (Tuesday, December 6, 2011)]
[Proposed Rules]
[Pages 76096-76097]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-31225]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1140
[Docket No. FDA-2011-N-0467]
RIN 0910-AG43
Non-Face-to-Face Sale and Distribution of Tobacco Products and
Advertising, Promotion, and Marketing of Tobacco Products; Extension of
Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Advance notice of proposed rulemaking; extension of comment
period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is extending the
comment period until January 19, 2012, for an advance notice of
proposed rulemaking (ANPRM) that was published in the Federal Register
of September 9, 2011 (76 FR 55835). In that document, FDA requested
comments, data, research, or other information related to non-face-to-
face sale and distribution of tobacco products; the advertising,
promotion, and marketing of such products; and the advertising of
tobacco products via the Internet, email, direct mail, telephone, smart
phones, and other communication technologies that can be directed to
specific recipients. The Agency is extending the comment period in
response to a request to give interested parties additional time to
comment.
DATES: Submit either electronic or written comments by January 19,
2012.
ADDRESSES: You may submit comments, identified by Docket No. FDA-2011-
N-0467 and/or RIN number 0910-AG43, by any of the following methods:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Written Submissions
Submit written submissions in the following ways:
FAX: (301) 827-6870.
Mail/Hand delivery/Courier (for paper, disk, or CD-ROM
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Instructions: All submissions received must include the Agency name
and Docket No. FDA-2011-N-0467 and Regulatory Information Number (RIN
0910-AG43) for this rulemaking. All comments received may be posted
without change to https://www.regulations.gov, including any personal
information provided. For additional information on submitting
comments, see the ``Comments'' heading of the SUPPLEMENTARY INFORMATION
section of this document.
Docket: For access to the docket to read background documents or
comments received, go to https://www.regulations.gov and insert the
docket number, found in brackets in the heading of this document, into
the ``Search'' box and follow the prompts and/or go to the Division of
Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Beth Buckler, Center for Tobacco
Products, Food and Drug Administration, 9200 Corporate Blvd.,
Rockville, MD 20850-3229, (877) 287-1373, beth.buckler@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of September 9, 2011 (76 FR 55835), FDA
issued an ANPRM to obtain information related to the regulation of non-
face-to-face sale and distribution of tobacco products and the
advertising, promotion, and marketing of tobacco products. FDA took
this action as part of its implementation of the Family Smoking
Prevention and Tobacco Control Act (Pub. L. 111-31, 123 Stat. 1776).
FDA requested comments, data, research, or other information related to
non-face-to-face sale and distribution of tobacco products; the
advertising, promotion, and marketing of such products; and the
advertising of tobacco products via the Internet, email, direct mail,
telephone, smart phones, and other communication technologies that can
be directed to specific recipients. FDA intends to use the information
submitted in response to the ANPRM to inform its regulation of the sale
and distribution of tobacco products through a non-face-to-face
exchange and the advertising, promotion, and marketing of tobacco
products. FDA provided a 90-day comment period (i.e., until December 8,
2011) for the ANPRM.
[[Page 76097]]
FDA has received a request to extend the comment period. The
request stated that additional time is needed to coordinate factual
information and policy positions with a large number of States on
several of the questions in the ANPRM. The request noted that their
comments will be more thorough and of more assistance to FDA if more
time is available to develop them.
FDA has considered the request and is extending the comment period
an additional 6 weeks, until January 19, 2012. We believe that the
additional time will provide interested parties sufficient time to
submit comments on the ANPRM.
II. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
ANPRM. It is only necessary to send one set of comments. It is no
longer necessary to send two copies of mailed comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.
Dated: December 1, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-31225 Filed 12-5-11; 8:45 am]
BILLING CODE 4160-01-P
